JP Morgan Chase
KMTS icon

JP Morgan Chase’s Kestra Medical Technologies KMTS Stock Holding History

JP Morgan Chase’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.52M Buy
86,835
+68,178
+365% +$1.74M ﹤0.01% 4080
2026
Q2 		$506K Sell
18,657
-7,129
-28% -$149K ﹤0.01% 5117
2026
Q1 		$473K Buy
25,786
+5,997
+30% +$141K ﹤0.01% 5075
2025
Q4 		$525K Buy
19,789
+5,364
+37% +$138K ﹤0.01% 4987
2025
Q3 		$343K Sell
14,425
-1,044
-7% -$18.7K ﹤0.01% 5239
2025
Q2 		$256K Buy
+15,469
New +$338K ﹤0.01% 5117

Other funds holding KMTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return

JP Morgan Chase's KMTS Position: Q3 2026 in Review

JP Morgan Chase increased its Kestra Medical Technologies (KMTS) stake by 365% in Q3 2026, buying an estimated $1.74M and bringing the position to 86,835 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #4080.

JP Morgan Chase first reported a position in KMTS in Q2 2025 and has held it in 6 quarters since. 46 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • JP Morgan Chase held 86,835 shares of Kestra Medical Technologies worth $2.52M as of Q3 2026.
  • JP Morgan Chase bought 68,178 Kestra Medical Technologies shares in Q3 2026, an estimated $1.74M.
  • Kestra Medical Technologies made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #4080 holding.
  • JP Morgan Chase first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 6 quarters since.
  • 46 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.